DSpace Repository

Levels of MicroRNA Heterogeneity in Cancer Biology

Show simple item record

dc.contributor.author Ergun, Sercan
dc.contributor.author Isenovic, Esma R.
dc.contributor.author Petrovic, Nina
dc.date.accessioned 2022-08-16T11:43:11Z
dc.date.available 2022-08-16T11:43:11Z
dc.date.issued 2017
dc.identifier.uri http://doi.org/10.1007/s40291-017-0285-9
dc.identifier.uri http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/1995
dc.description.abstract MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression, involved in the silencing of messenger RNA (mRNA) translation. The importance of miRNA signatures in disease screening, prognosis, and progression of different tumor types and subtypes is increasing. miRNA expression levels change depending on numerous factors. In this review, we are describing the circumstances under which miRNA levels can change, these are named 'levels' of heterogeneity of miRNAs. miRNAs can have oncogenic, tumor suppressive, or both roles depending on tumor type and target mRNA whose translation they silence. The expression levels of a single miRNA may vary across different cancer types and subtypes, indicating that a miRNA signature may be tissue specific. miRNA levels of expression also vary during disease formation and propagation, indicating the presence of a time profile for their expression. The complexity of the miRNA-mRNA interference network mirrors different genetic and epigenetic changes that influence miRNA and mRNA availability to each other, and hence, their binding ability. The potential role of miRNAs as biomarkers is two-fold; first, for monitoring of the phases of cancer pathogenesis, and second, to characterize the particular type/subtype of cancer. It is important that a particular miRNA should be characterized by examining as many types and subtypes of cancers as are available, as well as being extracted from different types of samples, in order to obtain a complete picture of its behavior and importance in the disease pathology. en_US
dc.language.iso eng en_US
dc.publisher ADIS INT LTD, 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND en_US
dc.relation.isversionof 10.1007/s40291-017-0285-9 en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject BREAST-CANCER; TUMOR-SUPPRESSOR; EXPRESSION SIGNATURE; MIR-17-92 CLUSTER; ESTROGEN-RECEPTOR; PROSTATE-CANCER; TARGET; PROGRESSION; MIR-21; CELLS en_US
dc.title Levels of MicroRNA Heterogeneity in Cancer Biology en_US
dc.type article en_US
dc.relation.journal MOLECULAR DIAGNOSIS & THERAPY en_US
dc.contributor.department Ordu Üniversitesi en_US
dc.contributor.authorID 0000-0002-6733-9848 en_US
dc.contributor.authorID 0000-0003-2503-1228 en_US
dc.identifier.volume 21 en_US
dc.identifier.issue 5 en_US
dc.identifier.startpage 511 en_US
dc.identifier.endpage 523 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account